Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
SAGE Open Medical Case Reports|December 16, 2017
A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearanceBrandon A Howard, Olga G James, Jennifer M Perkins, et al.Cancer Research|October 6, 2005
Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivoBrandon A Howard, Ryohei Furumai, Michael J Campa, et al.Nuclear Medicine Communications|April 23, 2016
Patient and tumor characteristics predictive of an elevated hepatopulmonary shunt fraction before radioembolization of hepatic tumorsVijay Yerubandi, James Ronald, Brandon A Howard, et al.Annals of Nuclear Medicine|July 10, 2017
Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CTBrandon A Howard, Rustain Morgan, Matthew P Thorpe, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerBrandon A Howard, Zhong Zheng, Michael J Campa, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.Hybridoma (2005)|July 23, 2008
Murine CD7 shares antigenic cross-reactivity with HSP-60Brandon A Howard, Gregory D Sempowski, Richard M Scearce, et al.Surgical Oncology|November 8, 2020
The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanomaSurya Ravichandran, Neel Nath, David C Jones, et al.Pageof 2